Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature

Felix K H Chun, Jonathan Ira Epstein, Vincenzo Ficarra, Stephen J. Freedland, Rodolfo Montironi, Francesco Montorsi, Shahrokh F. Shariat, Fritz H. Schröder, Vincenzo Scattoni

Research output: Contribution to journalArticle

Abstract

Context: The number and location of biopsy cores and the interpretation of prostate biopsy in different clinical settings remain the subjects of continuing debate. Objective: Our aim was to review the current evidence regarding the performance and interpretation of initial, repeat, and saturation prostatic biopsy. Evidence acquisition: A comprehensive Medline search was performed using the Medical Subject Heading search terms prostate biopsy, prostate cancer, detection, transrectal ultrasound (TRUS), nomogram, and diagnosis. Results were restricted to the English language, with preference given to those published within the last 3 yr. Evidence synthesis: At initial biopsy, a minimum of 10 but not >18 systematic cores are recommended, with 14-18 cores in glands ≥50 cm3. Biopsies should be directed laterally, and transition zone (TZ) cores are not recommended in the initial biopsy setting. Further biopsy sets, either as an extended repeat or as a saturation biopsy (≥20 cores) including the TZ, are warranted in young and fit men with a persistent suspicion of prostate cancer. An immediate repeat biopsy is not indicated for prior high-grade prostatic intraepithelial neoplasia diagnosis given an adequate extended initial biopsy. Conversely, biopsies with atypical glands that are suspicious but not diagnostic of cancer should be repeated within 3-6 mo. Overall recommendations for further biopsy sets (a third set or more) cannot be made. Transrectal ultrasound-guided systematic biopsies represent the standard-of-care method of prostate sampling. However, transperineal biopsies are an up-to-standard alternative. Conclusions: The optimal prostatic biopsy regimen should be based on the individualized clinical setting of the patient and should follow the minimum standard requirements reported in this paper.

Original languageEnglish (US)
Pages (from-to)851-864
Number of pages14
JournalEuropean Urology
Volume58
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Prostate
Biopsy
Prostatic Neoplasms
Medical Subject Headings
Prostatic Intraepithelial Neoplasia
Nomograms
Standard of Care
Language

Keywords

  • Optimal sampling
  • Prostate biopsy
  • Prostate cancer detection
  • Review

ASJC Scopus subject areas

  • Urology

Cite this

Chun, F. K. H., Epstein, J. I., Ficarra, V., Freedland, S. J., Montironi, R., Montorsi, F., ... Scattoni, V. (2010). Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature. European Urology, 58(6), 851-864. https://doi.org/10.1016/j.eururo.2010.08.041

Optimizing performance and interpretation of prostate biopsy : A critical analysis of the literature. / Chun, Felix K H; Epstein, Jonathan Ira; Ficarra, Vincenzo; Freedland, Stephen J.; Montironi, Rodolfo; Montorsi, Francesco; Shariat, Shahrokh F.; Schröder, Fritz H.; Scattoni, Vincenzo.

In: European Urology, Vol. 58, No. 6, 12.2010, p. 851-864.

Research output: Contribution to journalArticle

Chun, FKH, Epstein, JI, Ficarra, V, Freedland, SJ, Montironi, R, Montorsi, F, Shariat, SF, Schröder, FH & Scattoni, V 2010, 'Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature', European Urology, vol. 58, no. 6, pp. 851-864. https://doi.org/10.1016/j.eururo.2010.08.041
Chun, Felix K H ; Epstein, Jonathan Ira ; Ficarra, Vincenzo ; Freedland, Stephen J. ; Montironi, Rodolfo ; Montorsi, Francesco ; Shariat, Shahrokh F. ; Schröder, Fritz H. ; Scattoni, Vincenzo. / Optimizing performance and interpretation of prostate biopsy : A critical analysis of the literature. In: European Urology. 2010 ; Vol. 58, No. 6. pp. 851-864.
@article{3671780af965469d8e2831de90eb6905,
title = "Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature",
abstract = "Context: The number and location of biopsy cores and the interpretation of prostate biopsy in different clinical settings remain the subjects of continuing debate. Objective: Our aim was to review the current evidence regarding the performance and interpretation of initial, repeat, and saturation prostatic biopsy. Evidence acquisition: A comprehensive Medline search was performed using the Medical Subject Heading search terms prostate biopsy, prostate cancer, detection, transrectal ultrasound (TRUS), nomogram, and diagnosis. Results were restricted to the English language, with preference given to those published within the last 3 yr. Evidence synthesis: At initial biopsy, a minimum of 10 but not >18 systematic cores are recommended, with 14-18 cores in glands ≥50 cm3. Biopsies should be directed laterally, and transition zone (TZ) cores are not recommended in the initial biopsy setting. Further biopsy sets, either as an extended repeat or as a saturation biopsy (≥20 cores) including the TZ, are warranted in young and fit men with a persistent suspicion of prostate cancer. An immediate repeat biopsy is not indicated for prior high-grade prostatic intraepithelial neoplasia diagnosis given an adequate extended initial biopsy. Conversely, biopsies with atypical glands that are suspicious but not diagnostic of cancer should be repeated within 3-6 mo. Overall recommendations for further biopsy sets (a third set or more) cannot be made. Transrectal ultrasound-guided systematic biopsies represent the standard-of-care method of prostate sampling. However, transperineal biopsies are an up-to-standard alternative. Conclusions: The optimal prostatic biopsy regimen should be based on the individualized clinical setting of the patient and should follow the minimum standard requirements reported in this paper.",
keywords = "Optimal sampling, Prostate biopsy, Prostate cancer detection, Review",
author = "Chun, {Felix K H} and Epstein, {Jonathan Ira} and Vincenzo Ficarra and Freedland, {Stephen J.} and Rodolfo Montironi and Francesco Montorsi and Shariat, {Shahrokh F.} and Schr{\"o}der, {Fritz H.} and Vincenzo Scattoni",
year = "2010",
month = "12",
doi = "10.1016/j.eururo.2010.08.041",
language = "English (US)",
volume = "58",
pages = "851--864",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Optimizing performance and interpretation of prostate biopsy

T2 - A critical analysis of the literature

AU - Chun, Felix K H

AU - Epstein, Jonathan Ira

AU - Ficarra, Vincenzo

AU - Freedland, Stephen J.

AU - Montironi, Rodolfo

AU - Montorsi, Francesco

AU - Shariat, Shahrokh F.

AU - Schröder, Fritz H.

AU - Scattoni, Vincenzo

PY - 2010/12

Y1 - 2010/12

N2 - Context: The number and location of biopsy cores and the interpretation of prostate biopsy in different clinical settings remain the subjects of continuing debate. Objective: Our aim was to review the current evidence regarding the performance and interpretation of initial, repeat, and saturation prostatic biopsy. Evidence acquisition: A comprehensive Medline search was performed using the Medical Subject Heading search terms prostate biopsy, prostate cancer, detection, transrectal ultrasound (TRUS), nomogram, and diagnosis. Results were restricted to the English language, with preference given to those published within the last 3 yr. Evidence synthesis: At initial biopsy, a minimum of 10 but not >18 systematic cores are recommended, with 14-18 cores in glands ≥50 cm3. Biopsies should be directed laterally, and transition zone (TZ) cores are not recommended in the initial biopsy setting. Further biopsy sets, either as an extended repeat or as a saturation biopsy (≥20 cores) including the TZ, are warranted in young and fit men with a persistent suspicion of prostate cancer. An immediate repeat biopsy is not indicated for prior high-grade prostatic intraepithelial neoplasia diagnosis given an adequate extended initial biopsy. Conversely, biopsies with atypical glands that are suspicious but not diagnostic of cancer should be repeated within 3-6 mo. Overall recommendations for further biopsy sets (a third set or more) cannot be made. Transrectal ultrasound-guided systematic biopsies represent the standard-of-care method of prostate sampling. However, transperineal biopsies are an up-to-standard alternative. Conclusions: The optimal prostatic biopsy regimen should be based on the individualized clinical setting of the patient and should follow the minimum standard requirements reported in this paper.

AB - Context: The number and location of biopsy cores and the interpretation of prostate biopsy in different clinical settings remain the subjects of continuing debate. Objective: Our aim was to review the current evidence regarding the performance and interpretation of initial, repeat, and saturation prostatic biopsy. Evidence acquisition: A comprehensive Medline search was performed using the Medical Subject Heading search terms prostate biopsy, prostate cancer, detection, transrectal ultrasound (TRUS), nomogram, and diagnosis. Results were restricted to the English language, with preference given to those published within the last 3 yr. Evidence synthesis: At initial biopsy, a minimum of 10 but not >18 systematic cores are recommended, with 14-18 cores in glands ≥50 cm3. Biopsies should be directed laterally, and transition zone (TZ) cores are not recommended in the initial biopsy setting. Further biopsy sets, either as an extended repeat or as a saturation biopsy (≥20 cores) including the TZ, are warranted in young and fit men with a persistent suspicion of prostate cancer. An immediate repeat biopsy is not indicated for prior high-grade prostatic intraepithelial neoplasia diagnosis given an adequate extended initial biopsy. Conversely, biopsies with atypical glands that are suspicious but not diagnostic of cancer should be repeated within 3-6 mo. Overall recommendations for further biopsy sets (a third set or more) cannot be made. Transrectal ultrasound-guided systematic biopsies represent the standard-of-care method of prostate sampling. However, transperineal biopsies are an up-to-standard alternative. Conclusions: The optimal prostatic biopsy regimen should be based on the individualized clinical setting of the patient and should follow the minimum standard requirements reported in this paper.

KW - Optimal sampling

KW - Prostate biopsy

KW - Prostate cancer detection

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=78049471852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049471852&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2010.08.041

DO - 10.1016/j.eururo.2010.08.041

M3 - Article

C2 - 20884114

AN - SCOPUS:78049471852

VL - 58

SP - 851

EP - 864

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 6

ER -